-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Eratum: Clin Invest (2014) 4(2), 227-234.
Erratum: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Clinical trials to prevent/treat childhood asthma: methodologic issues
Scott T Weiss, Augusto A Litonjua
Commentary: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
Irreversible EGFR inhibitors in advanced non-small-cell lung carcinoma: rationale and clinical evidence
Deme John Karikios & Michael Joseph Boyer
Review: Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation
-
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto
Clinical Trail Outcomes: Clinical Investigation